Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/067829external-prioritypatent/WO2014033176A1/en
Application filed by Janssen R & D IrelandfiledCriticalJanssen R & D Ireland
Publication of CR20150059ApublicationCriticalpatent/CR20150059A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Inhibidores de la replicación del virus de la hepatitis B (VHB) de la fórmula I, incluidas sus formas estereoquimicamente isoméricas y sales, hidratos y solvatos, en donde B, R1, R2 y R4 tienen el significado definido.Hepatitis B virus (HBV) replication inhibitors of the formula I, including its stereochemically isomeric forms and salts, hydrates and solvates, wherein B, R1, R2 and R4 have the definite meaning.
CR20150059A2012-08-282015-02-09
SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
CR20150059A
(en)